Fuzzy Wale Compression Stockinet for Peripheral Arterial Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether a new type of compression stocking, called Fuzzy Wale, can speed healing and reduce costs after a below-the-knee leg amputation. It compares this new treatment to regular compression stockings. Potential participants include those with peripheral arterial disease, a condition where narrowed arteries reduce blood flow to the limbs, who are scheduled for a below-the-knee amputation. Participants will use either the Fuzzy Wale stockings or the standard ones to determine which is more effective. As an unphased trial, this study provides a unique opportunity to contribute to innovative research that could enhance recovery and lower costs for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What prior data suggests that the Fuzzy Wale Compression Stockinet is safe for use in transtibial amputation patients?
Research has shown that Fuzzy Wale Compression Stockinet is likely safe for people with peripheral arterial disease. One study found this type of compression safe for those with blocked arteries, known as arterial occlusive disease. Participants in that study experienced healing with this compression method. These findings suggest the treatment is well-tolerated. The available data reported no serious side effects, offering some reassurance about safety for those considering joining the trial.12345
Why are researchers excited about this trial?
Fuzzy Wale Compression Stockinet is unique because it offers a new approach to aiding recovery after transtibial amputation in patients with peripheral arterial disease. Unlike the standard compression stockinet used today, this innovative stockinet is designed to be used for 4-8 weeks post-surgery or until prosthetic fitting, aiming to support full and durable wound healing. Researchers are excited about its potential to improve healing outcomes and enhance comfort during the critical recovery phase, potentially leading to quicker and more effective rehabilitations.
What evidence suggests that the Fuzzy Wale Compression Stockinet is effective for peripheral arterial disease?
This trial will compare the Fuzzy Wale Compression Stockinet with standard care for patients with peripheral arterial disease requiring transtibial amputation. Research has shown that the Fuzzy Wale Compression Stockinet may aid healing after below-the-knee amputation. In past cases, patients using this stockinet experienced noticeable healing improvements in about 8 weeks. The stockinet gently compresses the leg, which can enhance blood flow and accelerate healing. Although more research is needed, early results are promising for individuals with poor blood circulation. This treatment could reduce healing time and lower costs.23456
Who Is on the Research Team?
Matthew Melin, M.D.
Principal Investigator
Mayo Clinic
Are You a Good Fit for This Trial?
This trial is for individuals who have had a below-the-knee amputation due to peripheral arterial disease. The study aims to include those who require post-surgical healing support.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Pre-operative
Fuzzy Wale Compression Stockinet applied 3-7 days pre-operatively
Post-operative Treatment
Fuzzy Wale Compression Stockinet utilized for 4-8 weeks post-operatively or until prosthetic fitting and wound has achieved full durable healing
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Fuzzy Wale Compression Stockinet
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mayo Clinic
Lead Sponsor